Anthemis, a leading early-stage investment firm, and Cambridge AI Venture Partners (CAIVP), a team comprised of industry experts Sir Andy Hopper, Prof. Rob Mullins, Dr Gavin Ferris and Mike Halsall, ...

Innovation in RNA-based, immunotherapy and targeted therapeutics is not just aspirational, it's urgently needed. Aggressive ...